Jean?Phillip Okhovat|Derek Beaulieu|Hensin Tsao|Allan C. Halpern|Dominique S. Michaud|Shimon Shaykevich|Alan C. Geller
The first 30 years of the American Academy of Dermatology skin cancer screening program: 1985-2014
Stanford Health Care|Beth Israel Deaconess Medical Center|Harvard University|Tufts University|Massachusetts General Hospital|Harvard University|Memorial Sloan Kettering Cancer Center|Brigham and Women's Hospital|Harvard University|Harvard University
background incidence melanoma rising faster preventable cancer united states american academy dermatology sponsored free skin cancer education screenings conducted volunteer dermatologists united states since 1985 objective aimed assess american academy dermatologys national skin cancer screening program 1986 2014 analyzing risk factor profile access dermatologic services examination results methods conducted several detailed statistical analyses screening population results 1986 2014 records available 2046531 screenings 1963141 96 subjected detailed analysis men comprised 38 participants number annual screenings reached approximately 100000 1990 remained relatively stable thereafter 1991 2014 data 1995 1996 2000 unavailable clinical diagnoses rendered 20628 melanomas 156087 dysplastic nevi 32893 squamous cell carcinomas 129848 basal cell carcinomas 21 screenees regular dermatologist clinical diagnosis skin cancer likely general screening population uninsured limitations inability verify clinical diagnoses histopathologically conclusion findings suggest spotme program detected thousands skin cancers may gone undetected experienced delay detection incidence melanoma rising faster preventable cancer united states american academy dermatology sponsored free skin cancer education screenings conducted volunteer dermatologists united states since 1985 aimed assess american academy dermatologys national skin cancer screening program 1986 2014 analyzing risk factor profile access dermatologic services examination results conducted several detailed statistical analyses screening population 1986 2014 records available 2046531 screenings 1963141 96 subjected detailed analysis men comprised 38 participants number annual screenings reached approximately 100000 1990 remained relatively stable thereafter 1991 2014 data 1995 1996 2000 unavailable clinical diagnoses rendered 20628 melanomas 156087 dysplastic nevi 32893 squamous cell carcinomas 129848 basal cell carcinomas 21 screenees regular dermatologist clinical diagnosis skin cancer likely general screening population uninsured inability verify clinical diagnoses histopathologically findings suggest spotme program detected thousands skin cancers may gone undetected experienced delay detection